• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Will Aperio Survive

Anonymous

Guest
This company was a world leader in Digital Pathology and helped create this emerging market. But due to poor leadership, lack of vison and huge Ego's; they are going down and down fast. The new players in the market will cripple them within two years.
 




This company was a world leader in Digital Pathology and helped create this emerging market. But due to poor leadership, lack of vison and huge Ego's; they are going down and down fast. The new players in the market will cripple them within two years.

Based on all the people that helped creat this company and are now leaving, I believe we are doomed.

I am new to this site and noticed a board called "LOST CIVILIZATIONS", Well we will be on that in about 18 months, I GUARRREEENNTTEEEE!!!!